Regenerative Medicine Boca Raton Florida: The SB 1768 Patient Guide for 2026

On July 1, 2025, Florida crossed a regulatory threshold that quietly reshaped the regenerative medicine landscape. With the passage of Senate Bill 1768, the state established the first clear legal framework authorizing licensed physicians to administer non-FDA-approved stem cell therapies for orthopedic conditions, wound care, and pain management. For patients in Boca Raton, this was more than a legislative footnote. It transformed how clinics can market their services, what they must disclose, and how patients can protect themselves.

Boca Raton sits at the center of this shift. With 28.4% of its residents aged 65 and older, roughly $3.2 billion in annual healthcare spending, and 47 active adult communities, the city represents one of the most concentrated regenerative medicine markets in the United States. Demand here is not hypothetical; it is built into the demographics.

Yet a striking gap remains. Most clinic websites do not address SB 1768, do not explain the FDA non-approval status of these therapies, and do not show patients how to use the law as a protective tool. This guide closes that gap. It equips Boca Raton patients with the legal knowledge, vetting criteria, and clinical context needed to distinguish legitimate providers from fraudulent operators. It also introduces Unicorn Bioscience (200 Glades Rd #2, Boca Raton, FL 33432) as a provider that operates transparently within the SB 1768 framework.

Why Boca Raton Is Ground Zero for Regenerative Medicine in Florida

Boca Raton’s profile reads like a regenerative medicine market analyst’s wish list. The median age is 46 years, and between 28.4% and 28.7% of residents are 65 or older, a figure that dramatically exceeds Florida’s statewide senior rate of 21.8%, which is itself among the highest in the nation.

Affluence reinforces demand. With a median household income of $106,273 and a cost of living running 17% above the national average, the city supports the cash-pay pricing models standard in regenerative medicine, where most therapies lack insurance reimbursement. The 47 active adult communities for residents 55 and older create a built-in patient base actively seeking non-surgical orthopedic solutions.

This demand is not a passing trend. The age-85-and-older population in southeast Florida is projected to more than double by 2050, signaling sustained long-term need for joint, tendon, and soft tissue care.

The city’s credibility as a regenerative hub was reinforced in January 2026, when the Gift of Life Marrow Registry, headquartered in Boca Raton, celebrated the expansion of its stem cell collection center, now the largest registry-operated unrelated donor stem cell collection facility in the world. That infrastructure milestone underscores the region’s standing in cellular science.

Globally, the regenerative medicine market is projected to grow from approximately $58 billion to $73 billion in 2026 to more than $360 billion by 2034, with orthopedics holding the largest segment share. Boca Raton is positioned to capture an outsized portion of that growth.

Understanding Florida SB 1768: What the Law Actually Says

SB 1768 passed with rare unanimity: 37 to 0 in the Florida Senate and 112 to 0 in the House. That consensus positioned Florida as a national leader in regulated regenerative medicine access.

The law authorizes licensed Florida physicians, specifically MDs and DOs operating under Chapter 458 or 459, to administer non-FDA-approved stem cell therapies for three defined purposes: orthopedic conditions, wound care, and pain management. Enforcement of compliance falls to the Florida Department of Health, not the FDA. That jurisdictional distinction is critical.

It is equally important to understand what SB 1768 does not do. The law does not grant FDA approval to any treatment. It does not extend authority to non-physician providers. And it does not override federal law. Legal analysts at Holland & Knight have flagged that SB 1768 stands in direct conflict with the federal Food, Drug, and Cosmetic Act, leaving it unclear how, or whether, the FDA will enforce against Florida-based treatments administered under the new statute.

For patients, the practical takeaway is this: SB 1768 creates a framework of accountability, giving patients concrete criteria to evaluate whether a clinic is operating legally within Florida.

The Four Mandatory Disclosures SB 1768 Requires Every Compliant Clinic to Provide

The law’s protective power lives in its disclosure requirements. A compliant Boca Raton clinic must provide all four of the following:

1. Informed consent. Patients must sign explicit written consent acknowledging that the therapy is not FDA-approved, along with disclosure of known risks, available alternatives, and the experimental nature of the treatment.
2. FDA-registered sourcing. Clinics must use stem cell products sourced from FDA-registered facilities. Patients have every right to request documentation confirming sourcing compliance.
3. Post-thaw viability analysis. Clinics must provide reports confirming the cellular product is viable at the time of administration.
4. Advertising disclaimers. All marketing materials, including websites, brochures, and social media, must clearly state that the therapies are not FDA-approved.

Practical patient tip: Use these four requirements as a checklist. A clinic that cannot or will not provide these disclosures is not operating in SB 1768 compliance, and that is a clear signal to walk away.

Florida’s History With Stem Cell Fraud: Why This Law Matters

SB 1768 did not emerge in a vacuum. It responded to a documented problem. A 2021 survey found that Florida had the highest number of unlicensed stem cell clinics per capita in the United States.

The consequences of that environment were serious. The FDA has documented adverse events from unapproved regenerative therapies administered at unregulated clinics, including blindness, tumor formation, and infections. Prior to SB 1768, the agency issued warning letters to multiple Florida-based stem cell providers and obtained at least one permanent injunction against a Florida clinic.

The risk has not vanished. Researchers have warned that hundreds of clinics nationwide continued to offer unapproved stem cell treatments through late 2025. SB 1768 does not eliminate bad actors. What it does is establish a legal standard that legitimate providers must meet and that patients can verify. The distinction between a licensed physician operating under SB 1768 and an unlicensed operator is now codified in law, and patients finally have the tools to check.

How to Vet a Regenerative Medicine Clinic in Boca Raton: A Step-by-Step Patient Checklist

Patients preparing to evaluate a provider can use the following actionable steps:

• Step 1: Verify physician licensure. Confirm the treating provider is a licensed MD or DO in Florida under Chapter 458 or 459. Use the Florida Department of Health license lookup tool.
• Step 2: Request the SB 1768 informed consent document. A compliant clinic will have a signed form explicitly stating the therapy is not FDA-approved.
• Step 3: Ask about sourcing. Request documentation that the cellular product originates from an FDA-registered facility.
• Step 4: Request the post-thaw viability report. This is a non-negotiable requirement. Inability to provide it is a red flag.
• Step 5: Review the clinic’s advertising. Does the website include the required disclaimer that therapies are not FDA-approved? Absence signals non-compliance.
• Step 6: Evaluate clinical transparency. Does the clinic acknowledge FDA non-approval status while explaining the SB 1768 framework? Transparent providers educate; fraudulent ones obscure.
• Step 7: Assess imaging guidance. Legitimate orthopedic procedures should be administered under ultrasound or X-ray guidance for precision and safety.
• Step 8: Look for personalized treatment planning. Reputable providers assess individual factors such as age, inflammation levels, injury type, medications, and health goals rather than offering one-size-fits-all protocols.

What Regenerative Medicine Treatments Are Available in Boca Raton Under SB 1768

Before reviewing specific therapies, one point bears repeating: as of 2026, the FDA has not approved stem cell, PRP, or exosome products specifically for orthopedic conditions. This applies to every provider, including fully compliant ones. SB 1768 permits licensed Florida physicians to administer these therapies for orthopedic conditions, wound care, and pain management within the state’s regulatory framework.

Platelet-Rich Plasma (PRP) Therapy

PRP is derived from the patient’s own blood. Concentrated platelets are injected to accelerate healing in tendons, ligaments, and joints. Because it is autologous (self-derived), the risk of immune reaction is low. PRP is commonly used for osteoarthritis, rotator cuff injuries, tennis elbow, plantar fasciitis, and meniscus conditions, and it remains among the most clinically studied regenerative therapies.

Stem Cell Therapy and Bone Marrow Aspiration Concentrate (BMAC)

BMAC is harvested from the patient’s own bone marrow, concentrated, and injected into the target area. As an autologous, physician-administered approach, it fits squarely within the SB 1768 framework. Stem cell therapy commands roughly 43.8% of the regenerative medicine market in 2025, and 224 global clinical trials are currently investigating stem cell therapies for osteoarthritis, including a major Phase III trial funded with $140 million announced in January 2026.

Unicorn Bioscience reports that more than 90% of its stem cell patients have not gone on to knee replacement surgery, a meaningful metric for patients weighing alternatives. Broader research suggests that up to 80% of patients told they need total knee replacement may not actually require surgery, reinforcing the value of exploring regenerative options first.

Exosome Therapy

Exosomes are extracellular vesicles that facilitate cellular communication and carry growth factors, proteins, and genetic material. Clinical data indicates exosomes contain nearly three times the growth factors found in adult stem cells and may increase collagen production sixfold. An important caveat applies: long-term outcome data remains limited, a fact transparent providers acknowledge openly. Patients should ask any provider to explain the current evidence base honestly.

Hyaluronic Acid Viscosupplementation

Injections of hyaluronic acid restore joint lubrication and reduce pain, particularly in osteoarthritic knees. This is one of the more established and widely studied regenerative injection therapies, often used as part of a multi-modal protocol alongside PRP or BMAC.

Peptide Therapy

Peptide treatments are designed to support tissue repair and regeneration at the cellular level. This emerging modality has drawn growing interest in orthopedic and sports medicine. Patients should ask providers to explain the specific peptides used, their mechanism of action, and the current state of clinical evidence.

Conditions Treated: Who Is a Candidate for Regenerative Medicine in Boca Raton

Regenerative medicine addresses a range of orthopedic conditions:

• Osteoarthritis: the most common indication, with more than 595 million cases globally in 2024. Boca Raton’s senior-heavy population makes this the dominant local use case.
• Rotator cuff injuries: common among the city’s active adult, golf, and tennis communities.
• Meniscus injuries: a frequent sports and age-related injury where regenerative approaches may delay or prevent surgery.
• Tendon injuries: including Achilles tendinopathy, patellar tendinopathy, and tennis or golfer’s elbow.
• Ligament tears: partial tears may respond to regenerative injection therapies.
• Plantar fasciitis: highly prevalent among active adults and runners.
• Spine and neck conditions: including degenerative disc disease and facet joint pain.
• Hip injuries: including labral tears and hip osteoarthritis.

Not every patient is a candidate. Personalized assessment by a qualified physician is essential to determine appropriateness.

Regenerative Medicine vs. Traditional Treatments: Understanding the Clinical Context

The following context is intended to support informed conversations with a physician, not to serve as a recommendation.

The Case Against Repeated Cortisone Injections

Studies document adverse effects of repeated cortisone injections, including ligament and tendon weakening, cartilage damage, worsened arthritis progression, and increased osteoporosis risk. Many patients seek regenerative alternatives after experiencing diminishing returns or side effects from corticosteroid injections. Where cortisone suppresses inflammation temporarily, regenerative therapies aim to address the underlying tissue damage.

Regenerative Alternatives to Joint Replacement Surgery

More than 600,000 knee replacements are performed annually in the United States. Research suggests up to 80% of patients told they need total knee replacement may not actually require surgery, a statistic that warrants thorough evaluation of non-surgical options. Regenerative therapies represent a clinically meaningful step in the treatment continuum before committing to an irreversible procedure. Patients who have already failed conservative treatments such as physical therapy, NSAIDs, and cortisone are often the strongest candidates.

Unicorn Bioscience Boca Raton: SB 1768 Compliance and Transparent Care

Located at 200 Glades Rd #2, Boca Raton, FL 33432, Unicorn Bioscience serves Boca Raton and the broader South Florida region with a care model built around transparency.

The clinic explicitly acknowledges on its website that, as of 2026, the FDA has not approved stem cell, PRP, or exosome products specifically for orthopedic conditions. That disclosure aligns directly with SB 1768’s mandatory transparency requirements. Treatments are administered by or under the supervision of board-certified physicians, meeting the law’s licensed MD or DO requirement.

All injections are administered using ultrasound and/or X-ray imaging guidance for accurate delivery and enhanced safety. Treatment protocols are individualized based on inflammation levels, patient age, injury type, current medications, and personal health goals rather than a fixed menu. The clinic offers a multi-modal approach spanning PRP, stem cell therapy, BMAC, exosome therapy, hyaluronic acid, and peptide therapy, with same-day treatment available for qualified candidates. Both virtual and in-person consultations accommodate local residents, South Florida patients, and out-of-state travelers.

Leadership credentials reinforce that posture. Dr. Aldaas is board-certified, completed his family medicine residency at Ellis Hospital, and served as Assistant Professor of Medicine at Albany Medical Center. Josh Simpson, MS-PAC, trained in orthopedic surgery at Johns Hopkins and gained experience in orthopedic trauma at a leading orthopedic institution.

SB 1768 and Medical Tourism: Why Out-of-State Patients Are Coming to Boca Raton

Florida’s SB 1768 creates a legal pathway for treatments that remain unavailable or legally ambiguous in many other states. Patients from states without comparable legislation may travel to Boca Raton specifically to access physician-administered regenerative therapies within a defined regulatory framework.

Boca Raton’s infrastructure supports this flow: convenient access through Fort Lauderdale-Hollywood and Palm Beach International airports, luxury accommodations, and an established medical tourism ecosystem. Snowbirds and seasonal residents already familiar with the city’s healthcare landscape form a natural medical tourism segment. Unicorn Bioscience’s virtual consultation option allows out-of-state patients to begin the evaluation process before traveling. Anyone considering medical travel should verify that the Florida provider meets all SB 1768 compliance requirements using the vetting checklist in this guide.

Frequently Asked Questions: Regenerative Medicine and SB 1768 in Boca Raton

Is stem cell therapy legal in Boca Raton, Florida?
Yes. Under SB 1768, effective July 1, 2025, licensed Florida MDs and DOs may administer non-FDA-approved stem cell therapies for orthopedic conditions, wound care, and pain management.

Does SB 1768 mean stem cell therapy is FDA-approved?
No. The FDA has not approved stem cell, PRP, or exosome products for orthopedic conditions as of 2026. SB 1768 creates a state-level framework for physician administration with mandatory disclosures.

What should a compliant clinic provide?
Signed informed consent disclosing non-FDA-approval status, documentation of FDA-registered sourcing, a post-thaw viability report, and advertising that includes the required disclaimer.

Is insurance likely to cover regenerative medicine treatments?
Most regenerative therapies lack insurance reimbursement and are offered on a cash-pay basis. Boca Raton’s affluent demographics mean many residents can invest in advanced care without insurance dependency.

How do I know if a Boca Raton clinic is operating legally under SB 1768?
Use the eight-step vetting checklist in this guide. The most important factors are a licensed MD or DO, signed informed consent, FDA-registered sourcing documentation, and a post-thaw viability report.

Can patients travel from another state to receive treatment in Boca Raton?
Yes. SB 1768 applies to treatments administered in Florida by Florida-licensed physicians. Out-of-state patients may legally receive these treatments in Boca Raton.

What conditions are most commonly treated?
Osteoarthritis, rotator cuff injuries, meniscus injuries, tendinopathies, ligament tears, plantar fasciitis, and spine, hip, and knee conditions.

How long does a treatment take?
Many procedures are same-day. Qualified candidates may receive treatment on the same day as their consultation.

Conclusion: Using SB 1768 as a Patient Protection Tool in Boca Raton

Florida’s SB 1768 is not merely a law for providers. It is a patient protection framework that gives Boca Raton residents concrete tools to distinguish legitimate regenerative medicine clinics from unlicensed operators. The four mandatory disclosures (informed consent, FDA-registered sourcing, a post-thaw viability report, and advertising disclaimers) form the patient’s non-negotiable baseline.

Honest complexity remains. SB 1768 does not make these therapies FDA-approved, and the federal-state regulatory tension is unresolved. Informed patients understand that nuance and proceed with clear expectations.

With 28.4% of residents aged 65 and older, roughly $3.2 billion in annual healthcare spending, and world-class infrastructure including the Gift of Life expansion, Boca Raton is uniquely positioned to benefit from responsible, transparent regenerative care. As a provider that openly discloses FDA non-approval status, operates under physician leadership, uses precision imaging guidance, and offers personalized multi-modal protocols, Unicorn Bioscience exemplifies the compliance standard patients should demand. The best outcomes begin with an informed patient asking the right questions, and this guide has supplied them.

Ready to Explore Regenerative Medicine in Boca Raton? Schedule a Consultation

Patients ready to take the next step can connect with Unicorn Bioscience at 200 Glades Rd #2, Boca Raton, FL 33432. Both virtual and in-person consultations are available for local residents, South Florida patients, and out-of-state medical travelers. Qualified candidates may receive same-day treatment, reducing friction for those ready to act.

Patients are encouraged to bring the SB 1768 vetting checklist from this article to their consultation. Unicorn Bioscience welcomes informed patients and transparent conversations. To learn more, call (737) 347-0446 or visit unicornbioscience.com.

A consultation is an opportunity to ask questions, review candidacy, and receive a personalized treatment assessment. It is not a commitment to proceed.